The latest price of Assimini in 2024

Asciminib (Asciminib) is a cancer drug. It is used to treat chronic myelogenous leukemia (CML), a cancer of white blood cells that is in the "chronic" stage (i.e., the disease develops slowly and patients have few or no symptoms). This drug is available to adults whose cancer is Philadelphia chromosome positive (Ph+). Ph+ means that the patient's two chromosomes have rearranged to form a special chromosome called the Philadelphia chromosome. This chromosome produces an enzyme, BCR::ABL1 kinase, which leads to the development of leukemia. Aceminib is mainly used in patients who have been treated with two or more cancer drugs called tyrosine kinase inhibitors.

Aximini is available as an oral tablet. Usually taken once or twice daily on an empty stomach (at least 1 hour before or 2 hours after meals). Take aceminix at about the same time each day, and do not take more or less than your doctor prescribes. Swallow Asiminib tablets whole; do not split, chew, or crush them. Doctors may adjust the dose or temporarily or permanently stop treatment with aximinib based on the patient's response to treatment and any side effects experienced. Continue taking Asiminib even if you feel fine.

Acemini's original drug is not marketed in China, so it cannot be included in medical insurance, and its price is not clear. The European version of Asiminib's original research drug currently sold overseas has a common specification of 40mg*60 tablets, and the price per box may be more than 40,000 yuan (the price may fluctuate due to exchange rates). At the same time, there are also generic drugs of Asiminib available for sale overseas. The ingredients of the drugs are basically the same as those of the original drugs. For example, the specifications of 40mg*60 tablets produced by Laos Pharmaceutical Factory may be sold at more than 4,000 yuan per box (the price may fluctuate due to the exchange rate), and the price is relatively cheap.